We are translational research scientists focused on making health assessment and biological age metrics accessible for everyone.
Shabnam Salimi, MD, MSc, FAHA
Dr. Shabnam Salimi, MD, MSc, is the CEO of Health Octo Genome and a translational physician-scientist whose research focuses on biological aging as a fundamental mechanism underlying chronic disease. She integrates personalized health data with multi-omics approaches—including metabolomics, proteomics, genetic sequencing, and epigenetics—to better understand how aging affects organ systems across the lifespan. As the developer of the Health Octo Tool, a digital platform designed to assess organ-specific health patterns and biological aging metrics, Dr. Salimi translates cutting-edge aging science into accessible, actionable health insights to support proactive, personalized approaches to healthy aging for individuals, clinicians, and researchers.
Daniel Raftery, PhD
Daniel Raftery, PhD, MBA, Professor at the University of Washington and Director of the Northwest Metabolomics Research Center, serves as a Scientific Advisor to Health Octo Genome. Dr. Raftery is an expert in metabolic changes in aging and disease and has been involved in startup companies for many years.
Our mission is to bridge scientific innovation and public health by making aging-related insights accessible, actionable, and equitable—helping individuals and populations live healthier, longer lives.